| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.4M | -95.4% |
| R&D Expense | $246.4M | +42.7% |
| SG&A Expense | $66.0M | +15.0% |
| Operating Income | -$299.3M | +17.9% |
| Income Tax | $0 | — |
| Net Income | -$290.5M | +20.2% |
| EPS (Basic) | -$2.59 | +32.2% |
| EPS (Diluted) | -$2.59 | +32.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $151.8M | -45.8% |
| Accounts Receivable | $306K | -24.1% |
| Current Assets | $1.02B | +4.4% |
| Total Assets | $1.10B | +9.1% |
| Current Liabilities | $63.7M | +162.0% |
| Total Liabilities | $149.6M | +35.2% |
| Stockholders' Equity | $950.2M | +5.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$229.5M | -208.4% |
| Capital Expenditures | $9.1M | +161.1% |
| Investing Cash Flow | -$188.7M | +60.6% |
| Financing Cash Flow | $289.9M | -25.3% |
| Free Cash Flow | -$238.6M | -206.3% |